Lou Yiling, Wang Hengchang, Wang Linlin, Huang Shen, Xie Yulin, Song Fujian, Lu Zuxun, Wang Furong, Jiang Qingqing, Cao Shiyi
School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, No. 13 Hangkong Road, Wuhan 430030, China.
Norwich Research Park, Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK.
Nutrients. 2025 Aug 19;17(16):2683. doi: 10.3390/nu17162683.
This network meta-analysis aimed to assess the relative efficacy of macronutrient dietary groups with varying carbohydrate, fat, and protein ratios on weight control and cardiovascular risk factors improvement in adults. We searched PubMed, the Cochrane Central Register of Controlled Trials (CENTRAL), Embase, Web of Science Core Collection, and ClinicalTrials.gov from inception to 30 November 2024, as well as reference lists of related systematic reviews. Eligible randomized controlled trials (RCTs) were included. Literature screening, data extraction, and risk of bias assessment were conducted independently by two reviewers. The changes in body weight, blood glucose, systolic blood pressure, diastolic blood pressure, high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, triglycerides, and total cholesterol were the study outcomes. Utilizing a Bayesian framework, a series of random-effects network meta-analyses were conducted to estimate mean difference (MD) with 95% credible interval (CrI) and determine the relative effectiveness of the macronutrient dietary groups. The quality of evidence for each pair of dietary groups was assessed based on the online tool called confidence in network meta-analysis (CINeMA). This study initially identified 14,988 studies and ultimately included 66 eligible RCTs involving 4301 participants in the analysis. The very low carbohydrate-low protein (VLCLP, MD -4.10 kg, 95% CrI -6.70 to -1.54), the moderate carbohydrate-high protein (MCHP, MD -1.51 kg, 95% CrI -2.90 to -0.20), the very low carbohydrate-high protein (VLCHP, MD -1.35 kg, 95% CrI -2.52 to -0.26) dietary groups might lead to weight loss compared with the moderate fat-low protein (MFLP) dietary group. Among the dietary groups relative to the MFLP dietary group, the moderate carbohydrate-low protein (MCLP, MD 0.09 mmol/L, 95% CrI 0.02 to 0.16) and VLCHP (MD 0.16 mmol/L, 95% CrI 0.08 to 0.24) dietary groups were less effective in lowering HDL cholesterol, and the VLCHP (MD 0.50 mmol/L, 95% CrI 0.26 to 0.75) dietary group was less effective in lowering LDL cholesterol. In terms of triglyceride reduction, the MCLP (MD -0.33 mmol/L, 95% CrI -0.44 to -0.22), VLCHP (MD -0.31 mmol/L, 95% CrI -0.42 to -0.18), VLCLP (MD -0.14 mmol/L, 95% CrI -0.25 to -0.02), and moderate fat-high protein (MFHP, MD -0.13 mmol/L, 95% CrI -0.21 to -0.06) dietary groups were more efficacious than the MFLP dietary group, while any pair of dietary group interventions showed minimal to no difference in the effects on blood glucose, blood pressure, and total cholesterol. High or moderate certainty evidence reveals that the VLCLP dietary group is the most appropriate for weight loss, while the MCLP dietary group is best for reducing triglycerides. For control of blood glucose, blood pressure, and cholesterol levels, there is little to no difference between macronutrient dietary groups. Additionally, future studies in normal-weight populations are needed to verify the applicability of our findings.
这项网络荟萃分析旨在评估碳水化合物、脂肪和蛋白质比例各异的常量营养素饮食组对成年人控制体重和改善心血管危险因素的相对疗效。我们检索了PubMed、Cochrane对照试验中央注册库(CENTRAL)、Embase、科学网核心合集以及ClinicalTrials.gov,检索时间从各数据库建库至2024年11月30日,同时检索了相关系统评价的参考文献列表。纳入符合条件的随机对照试验(RCT)。由两名评价员独立进行文献筛选、数据提取和偏倚风险评估。研究结局包括体重、血糖、收缩压、舒张压、高密度脂蛋白(HDL)胆固醇、低密度脂蛋白(LDL)胆固醇、甘油三酯和总胆固醇的变化。利用贝叶斯框架,进行了一系列随机效应网络荟萃分析,以估计平均差(MD)及其95%可信区间(CrI),并确定常量营养素饮食组的相对有效性。基于名为网络荟萃分析可信度(CINeMA)的在线工具评估每对饮食组的证据质量。本研究最初识别出14988项研究,最终纳入66项符合条件的RCT,共4301名参与者进行分析。与中脂肪 - 低蛋白(MFLP)饮食组相比,极低碳水化合物 - 低蛋白(VLCLP,MD -4.10 kg,95% CrI -6.70至 -1.54)、中碳水化合物 - 高蛋白(MCHP,MD -1.51 kg,95% CrI -2.90至 -0.20)、极低碳水化合物 - 高蛋白(VLCHP,MD -1.35 kg,95% CrI -2.52至 -0.26)饮食组可能导致体重减轻。在相对于MFLP饮食组的各饮食组中,中碳水化合物 - 低蛋白(MCLP,MD 0.09 mmol/L,95% CrI 0.02至0.16)和VLCHP(MD 0.16 mmol/L,95% CrI 0.08至0.24)饮食组在降低HDL胆固醇方面效果较差,而VLCHP(MD 0.50 mmol/L,95% CrI 0.26至0.75)饮食组在降低LDL胆固醇方面效果较差。在降低甘油三酯方面,MCLP(MD -0.33 mmol/L,95% CrI -0.44至 -0.22)、VLCHP(MD -0.31 mmol/L,95% CrI -0.42至 -0.18)、VLCLP(MD -0.14 mmol/L,95% CrI -0.25至 -0.02)和中脂肪 - 高蛋白(MFHP,MD -0.13 mmol/L,95% CrI -0.21至 -0.06)饮食组比MFLP饮食组更有效,而任何一对饮食组干预在对血糖、血压和总胆固醇的影响上差异极小或无差异。高或中度确定性证据表明,VLCLP饮食组最适合减肥,而MCLP饮食组最适合降低甘油三酯。对于控制血糖、血压和胆固醇水平,常量营养素饮食组之间几乎没有差异。此外,需要在正常体重人群中开展进一步研究以验证我们研究结果的适用性。
Cochrane Database Syst Rev. 2018-7-5
Cochrane Database Syst Rev. 2022-1-28
Cochrane Database Syst Rev. 2018-2-15
Cochrane Database Syst Rev. 2020-10-19
Cochrane Database Syst Rev. 2025-5-6
Cochrane Database Syst Rev. 2016-10-31
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2022-8-10
N Engl J Med. 2024-4-11
Crit Rev Food Sci Nutr. 2025
Diabetes Care. 2024-1-1
Campbell Syst Rev. 2020-3-11